Matthew Faber
Company: Xencor
Job title: Senior Scientist, Protein & Antibody Engineering
Seminars:
XmAb541, a Claudin 6-Targeted Bispecific Antibody Therapy for Targeting Solid Tumors 9:30 am
Preclinical development of XmAb541, a CLDN6 x CD3 bispecific antibody for selective targeting of CLDN6 expressing tumorsRead more
day: Conference Day 1